Most chemo drugs are approved by the U.S. Food and Drug Administration without evidence of benefit on survival or quality of life. If you put together all the new chemo drugs that had been approved over a dozen years, the average overall survival benefit is only 2.1 months.
Published on 4 months, 3 weeks ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate